Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Dec;16(12):467.
doi: 10.1007/s11926-014-0467-y.

The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis

Mark F Hoeltzel  1 , Edward J Oberle, Angela Byun Robinson, Arunima Agarwal, Lisa G Rider
Affiliations
Review

The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis

Mark F Hoeltzel et al. Curr Rheumatol Rep. 2014 Dec.

Abstract

Calcinosis is one of the hallmark sequelae of juvenile dermatomyositis (JDM), and despite recent progress in the therapy of JDM, dystrophic calcification still occurs in approximately one third of patients. This review discusses our current, albeit limited, understanding of risk factors for the development of calcinosis in JDM, as well as approaches to assessment, and current views on its pathogenesis. Anecdotal approaches to treating calcinosis associated with JDM, including both anti-inflammatory therapies and agents aimed at inhibiting the deposition of calcium hydroxyapatite, are reviewed. An improved understanding of the pathogenesis of calcinosis, the establishment of standardized measurement tools to assess calcinosis, and randomized controlled trials employing more sensitive outcome measures are needed to develop efficacious therapies for this often disabling complication.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Plain radiograph demonstrating sheet-like calcification in the lower leg of a 13 year old girl with JDM.
See this image and copyright information in PMC

References

    1. Rider LG, Lindsley C, Miller FW. Chapter 26: Juvenile dermatomyositis. In: Petty R, Laxer R, Wedderburn L, Lindsley C, editors. Textbook of Pediatric Rheumatology. 6. Saunders Elsevier; 2014. In press.
    1. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:344–7. 403–7. - PubMed
    1. Rider LG. Calcinosis in Juvenile Dermatomyositis: Pathogenesis and Current Therapies. Pediatr Rheumatol Online J. 2003;1:2.
    1. Ramanan AV, Feldman BM. Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am. 2002;28(4):833–58. - PubMed
    1. Fisler RE, Liang MG, Fuhlbrigge RC, et al. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol. 2002;47(4):505–11. - PubMed

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources